{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:46:37Z","timestamp":1793321197441,"version":"4.5.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>A 70-year-old Omani male with a history of poorly controlled diabetes, hypertension, and dyslipidemia presented with a 6-month history of persistent right ear and temporomandibular joint pain, culminating in sudden painless vision loss in the right eye and jaw claudication. Despite multiple prior consultations and misdiagnoses, the diagnosis of giant cell arteritis (GCA) was only made after ophthalmologic assessment revealed arteritic anterior ischemic optic neuropathy. Bilateral temporal artery biopsies confirmed GCA. The patient was managed with intravenous methylprednisolone, oral steroids, methotrexate, and later Tocilizumab. While systemic symptoms improved, vision loss was irreversible. This case underscores the diagnostic challenges of GCA in regions with low prevalence and highlights the importance of early recognition to prevent blindness.<\/jats:p>","DOI":"10.4103\/ojo.ojo_392_25","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T02:00:13Z","timestamp":1782266413000},"page":"256-258","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Delayed recognition of giant cell arteritis presenting as ear pain leading to vision loss: First biopsy-proven case encountered at a tertiary eye center in Oman"],"prefix":"10.4103","volume":"19","author":[{"given":"Noor Saif A.","family":"Al Jabri","sequence":"first","affiliation":[{"name":"Ophthalmology Programme, Oman Medical Specialty Board, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farida Wali M.","family":"Al Belushi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Al Nahdha Hospital, MOH, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"R1-20260624","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/bjo.2006.108845","article-title":"Epidemiology of giant-cell arteritis in an Arab population: A 22-year study","volume":"91","author":"Chaudhry","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R2-20260624","article-title":"Jaw claudication and jaw stiffness in giant cell arteritis: Analysis of a qualitative dataset","volume":"8","author":"Lim","year":"2023","journal-title":"Rheumatol Adv Pract"},{"key":"R3-20260624","first-page":"643","article-title":"Epidemiology of giant cell arteritis and polymyalgia rheumatica","volume":"51","author":"Salvarani","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R4-20260624","first-page":"65","article-title":"Giant cell arteritis: A rare cause of AAION in Saudi Arabia","volume":"14","author":"Al-Mujaini","year":"2007","journal-title":"Middle East Afr J Ophthalmol"},{"key":"R5-20260624","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00005792-200009000-00001","article-title":"Giant cell arteritis: Clinical patterns in 240 patients","volume":"79","author":"Gonzalez-Gay","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"R6-20260624","first-page":"1779","article-title":"Visual morbidity in giant cell arteritis","volume":"101","author":"Liu","year":"1994","journal-title":"Clinical characteristics and prognosis for vision"},{"key":"R7-20260624","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1056\/NEJMcp1214825","article-title":"Giant-cell arteritis and polymyalgia rheumatica","volume":"371","author":"Weyand","year":"2014","journal-title":"N Engl J Med"},{"key":"R8-20260624","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in giant-cell arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med"},{"key":"R9-20260624","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/art.11388","article-title":"Glucocorticoid therapy in giant cell arteritis:duration and adverse outcomes","volume":"49","author":"Proven","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R10-20260624","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/acr.24632","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis","volume":"73","author":"Maz","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R11-20260624","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2478\/rir-2023-0028","article-title":"Advances and challenges in management of large vessel vasculitis","volume":"4","author":"Chu","year":"2023","journal-title":"Rheumatol Immunol Res"},{"key":"R12-20260624","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/tjosr.tjosr_164_24","article-title":"Giant cell arteritis in the Middle East: A comprehensive systematic review and meta-analysis of prevalence, ocular manifestations, and systemic involvement","volume":"63","author":"Alsubhi","year":"2025","journal-title":"TNOA J Ophthalmic Sci Res"}],"container-title":["Oman Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ojo.ojo_392_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:26:27Z","timestamp":1787747187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ojo.ojo_392_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ojo.ojo_392_25","relation":{},"ISSN":["0974-620X","0974-7842"],"issn-type":[{"value":"0974-620X","type":"print"},{"value":"0974-7842","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2025-09-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}